A peer-educator network HIV prevention intervention among injection drug users: results of a randomized controlled trial in St. Petersburg, Russia.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3950300)

Published in AIDS Behav on September 01, 2013

Authors

Irving F Hoffman1, Carl A Latkin, Polina V Kukhareva, Sergey V Malov, Julia V Batluk, Alla V Shaboltas, Roman V Skochilov, Nicolay V Sokolov, Sergei V Verevochkin, Michael G Hudgens, Andrei P Kozlov

Author Affiliations

1: Division of Infectious Diseases, Department of Medicine, UNC Hospitals, University of North Carolina, CB # 7030, Chapel Hill, NC, 27599, USA. hoffmani@med.unc.edu

Associated clinical trials:

RCT of Russian IDU Peer Network HIV Prevention Intervention - 1 | NCT00218673

Articles cited by this

Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17

HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol (2003) 4.53

Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med (2003) 3.56

HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS (2006) 3.05

The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soc Sci Med (2008) 2.10

HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr (2006) 1.77

Commercial sex work, drug use, and sexually transmitted infections in St. Petersburg, Russia. Soc Sci Med (2004) 1.74

A network-individual-resource model for HIV prevention. AIDS Behav (2010) 1.69

The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction (2010) 1.48

Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy (2007) 1.41

Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. Eur J Public Health (2010) 1.37

Estimation of the number of injection drug users in St. Petersburg, Russia. Drug Alcohol Depend (2010) 1.15

Social influence in the theory of planned behaviour: the role of descriptive, injunctive, and in-group norms. Br J Soc Psychol (2008) 1.01

Correlates of unsafe equipment sharing among injecting drug users in St. Petersburg, Russia. Eur Addict Res (2009) 0.93

Articles by these authors

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis (2006) 5.24

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis (2005) 5.14

Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr (2008) 3.14

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci Transl Med (2011) 3.08

HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS (2006) 3.05

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J Infect Dis (2003) 2.98

Comparison of group testing algorithms for case identification in the presence of test error. Biometrics (2007) 2.86

Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials. Biometrics (2003) 2.76

Evaluating candidate principal surrogate endpoints. Biometrics (2008) 2.74

Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet (2012) 2.69

The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction (2006) 2.56

High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav (2010) 2.18

Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy (2008) 2.10

Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol (2008) 2.10

Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med (2007) 1.99

The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners. J Urban Health (2009) 1.95

Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr (2003) 1.89

Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One (2013) 1.83

HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology (2006) 1.83

Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr (2007) 1.82

HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr (2006) 1.77

The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend (2007) 1.75

Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health (2005) 1.67

The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res (2007) 1.65

Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. Soc Sci Med (2008) 1.65

Randomization inference for treatment effects on a binary outcome. Stat Med (2014) 1.62

Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines. J Acquir Immune Defic Syndr (2013) 1.56

Drug users' involvement in the drug economy: implications for harm reduction and HIV prevention programs. J Urban Health (2002) 1.55

Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Depend (2005) 1.50

Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates. Addiction (2005) 1.46

The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Addiction (2011) 1.46

Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis (2010) 1.41

The role of depressive symptoms in predicting sex with multiple and high-risk partners. J Acquir Immune Defic Syndr (2005) 1.41

Gender differences in social network influence among injection drug users: perceived norms and needle sharing. J Urban Health (2007) 1.40

Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl. Int J Biostat (2011) 1.40

Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission. AIDS (2008) 1.38

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials. J Infect Dis (2003) 1.38

A qualitative exploration of gender in the context of injection drug use in two US-Mexico border cities. AIDS Behav (2007) 1.38

Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. Eur J Public Health (2010) 1.37

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Int J Cancer (2010) 1.34

Social network characteristics and HIV sexual risk behavior among urban African American women. J Urban Health (2011) 1.32

Residential transience and HIV risk behaviors among injection drug users. AIDS Behav (2007) 1.31

Correlates of lending needles/syringes among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr (2007) 1.30

Results of a randomized controlled trial of a peer mentor HIV/STI prevention intervention for women over an 18 month follow-up. AIDS Behav (2011) 1.29

Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis (2007) 1.28

Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia. BMC Public Health (2010) 1.28

Highly efficient HIV transmission to young women in South Africa. AIDS (2007) 1.28

Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico. Int J Drug Policy (2008) 1.27

Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction (2009) 1.27

Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: the BESURE study. J Acquir Immune Defic Syndr (2011) 1.25

Interventions for seropositive injectors-research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr (2004) 1.25

Drug use in the social networks of heroin and cocaine users before and after drug cessation. Drug Alcohol Depend (2008) 1.25

Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine (2011) 1.23

"The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy (2008) 1.23

Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002. Public Health Rep (2005) 1.22

Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy. Aging Cell (2012) 1.21

Development of an opinion leader-led HIV prevention intervention among alcohol users in Chennai, India. AIDS Educ Prev (2004) 1.20

Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen. J Virol (2011) 1.20

Three-dimensional array-based group testing algorithms. Biometrics (2008) 1.18

Individual and social network factors that predict entry to drug treatment. Am J Addict (2007) 1.17

Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer (2010) 1.17

Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) (2013) 1.17

Causal inference for vaccine effects on infectiousness. Int J Biostat (2012) 1.15

A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia. J Infect Dis (2010) 1.15

The Role of Geographic and Network Factors in Racial Disparities in HIV Among Young Men Who have Sex with Men: An Egocentric Network Study. AIDS Behav (2015) 1.15

Social stability and HIV risk behavior: evaluating the role of accumulated vulnerability. AIDS Behav (2012) 1.13

A bridge over troubled waters: factors associated with non-injection drug users having injection drug-using sex partners. J Acquir Immune Defic Syndr (2006) 1.13

Exploring "wine shops" as a venue for HIV prevention interventions in urban India. J Urban Health (2007) 1.12

Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr (2005) 1.12

The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. J Urban Health (2003) 1.12

The effects of sponsorship in 12-step treatment of injection drug users. Drug Alcohol Depend (2002) 1.11

A social network perspective on heroin and cocaine use among adults: evidence of bidirectional influences. Addiction (2009) 1.10

The association between change in social network characteristics and non-fatal overdose: results from the SHIELD study in Baltimore, MD, USA. Drug Alcohol Depend (2006) 1.10

Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infect Dis J (2014) 1.10

Attitudes of Emergency Medical Service providers towards naloxone distribution programs. J Urban Health (2005) 1.08

HIV-related communication and perceived norms: an analysis of the connection among injection drug users. AIDS Educ Prev (2007) 1.07

Characteristics and predictors of HIV risk behaviors among injection-drug-using men and women in St. Petersburg, Russia. AIDS Educ Prev (2002) 1.07

Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men. Int J Cancer (2011) 1.07

Injecting equipment sharing in Russian drug injecting dyads. AIDS Behav (2009) 1.06

Social injecting and other correlates of high-risk sexual activity among injecting drug users in northern Vietnam. Int J Drug Policy (2008) 1.06

A qualitative study on commercial sex behaviors among male clients in Sichuan Province, China. AIDS Care (2010) 1.03

Multiple human papillomavirus infections and type competition in men. J Infect Dis (2011) 1.02

Correlates of HIV antibody testing among a sample of injection drug users: the role of social and contextual factors. AIDS Behav (2004) 1.02

Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania. Eur Addict Res (2010) 1.02

Individual and network interventions with injection drug users in 5 Ukraine cities. Am J Public Health (2010) 1.02

Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men. J Acquir Immune Defic Syndr (2007) 1.00

Social-level correlates of shooting gallery attendance: a focus on networks and norms. AIDS Behav (2010) 0.98

Correlates of abortions and condom use among high risk women attending an STD clinic in St. Petersburg, Russia. Reprod Health (2011) 0.98